Senior insider sale
Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$1.05M
36.76K shares
What this filing means
GOFF BRIAN plans to sell 36.76K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $1.05M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001439222-26-000030
DirectorOfficer· Chief Executive Officer
Since Mar 2026
36.76K
Shares to sell
$1.05M
Approx. market value
18.05K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Not Applicable
3/2/2026
18.05KTotal acquired18.05K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2026 | Vesting of Restricted Stock Units Not Applicable | 18.05K | — |
| Total | 18.05K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
18.70K
Market value
$506.7K
12/30/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
18.05K
Market value
$545.8K
3/2/2026
Total
Units
36.76K
Value
$1.05M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/30/2025 | 18.70K | $506.7K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 18.05K | $545.8K | Nasdaq | Planned |
| Total | 36.76K | $1.05M | ||